Mark S Cragg

49PUBLICATIONS
220CO-AUTHORS
NanomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyNaval architectureMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Nov 06, 2026
Duality Vaccination through Nanodesign of Click-Ligated B-Cell Inhibitory Receptor Bridging.

|Oct 15, 2026
Anti-TNFR2 antibody BI-1808 induces tumor regression and antitumor T cell immunity through T reg and myeloid cell modulation in patients with solid tumors.

|Oct 14, 2026
MicroRNA Expression in Macrophages Regulates Antibody-Dependent Effector Function and B-cell Lymphoma Therapy.

|Sep 26, 2026
Selinexor potentiates NK cell activation against multiple myeloma.

|Aug 23, 2026
ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.

|Jul 17, 2026
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity.

Pageof 9

Frequent Collaborators

10 joint publications

Stephen A Beers

8 joint publications

Sean H Lim

6 joint publications

Robert J Oldham

5 joint publications

Matthew D Blunt